Pär Larsson — ASN Events
  1. Schedule
  2. Pär Larsson

Par Larsson

Karolinska Institutet, , Sweden

  • This delegate is presenting an abstract at this event.
Presentations this author is a contributor to:

Preclinical evaluation of efficacy and safety of a new vaccine against Coxsackievirus B1 – Implications for type 1 diabetes development (#93)

5:05 PM
Pär Larsson
POSTER SESSION 1 / DRINKS